Using elegant precedence of ganglioside-mediated activation of growth factor receptor signaling, our work reveals that increased GD3 gangliosides in response to altered expression of UGCG boost the EGFR phosphorylation status and subsequent downstream growth signaling in luminal cancers. Here, UGCG is linked to cancer.